The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Trabecular bone remodeling and bone balance in hyperthyroidism
Abstract
In vivo tetracycline double-labeled iliac crest bone biopsies from 15 hyperthyroid patients were used for the reconstruction of curves describing the variation of resorption depth and formation thickness with time. The curves emerging were compared to curves reconstructed from 13 age- and sex-matched normal individuals (mean age 44 years). The median function period for resorptive cells in hyperthyroid patients (16 days) was about one-third the resorptive period in normals (51 days). No significant difference between the osteoclast-, mononuclear-, or preosteoblast-like cell resorption depths could be demonstrated between the two groups. Consequently, the median resorption rate in hyperthyroid patients (3.8 microns/day) was more than 3 times higher than the value in the control group (1.1 micron/day). Median Sigma, was shorter in the hyperthyroid group (109 days) than in the control group (151 days, P less than 0.05), as was the median initial mineralization lag time (5 and 16 days, respectively, P less than 0.01). No significant difference between the measured mean completed wall thickness (mcwT) values in the hyperthyroid groups and the control group could be demonstrated (58.1 and 60.5 micron respectively). Median initial mineralization rate in the hyperthyroid group (1.2 micron3/micron2 per day) was not significantly higher than the value calculated in the control group (0.9 micron3/micron2 per day), but median initial matrix appositional rate in hyperthyroid (4.8 microns3/micron2 per day) was 3 times higher than the value calculated for normals (1.6 micron3/micron2 per day) (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which can decrease bone quality22 and bone mineral density,60 leading to a higher risk of fracture.”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [60]
Citations
Cites
Tetracycline-based histological analysis of bone remodeling
Frost, H. M. (1969) · Calcified Tissue Research · doi:10.1007/bf02058664 · Cited by 1,111
THE EFFECT OF THYROID DISEASE ON CALCIUM METABOLISM IN MAN 1
Krane, S. M., Brownell, G. L., Stanbury, J. B., & Corrigan, H. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103340 · Cited by 227
Eriksen, E. F., Gundersen, H. J. G., Melsen, F., & Mosekilde, L. (1984) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(84)90066-3 · Cited by 198
Self-citationEriksen, E. F., Melsen, F., & Mosekilde, L. (1984) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(84)90065-1 · Cited by 196
Self-citationBony Manifestations of Thyrotoxicosis
Meunier, P. J., Gs, B., Edouard, C. M., Bernard, J., Courpron, P., & Vignon, G. (1972) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)30490-9 · Cited by 165
Mosekilde, L., & Melsen, F. (1978) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1978.tb08406.x · Cited by 148
Self-citationMorphometric and Dynamic Studies of Bone Changes in Hypothyroidism
Mosekilde, L., & Melsen, F. (1978) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1978.tb02012.x · Cited by 140
Self-citationEFFECTS OF HYPERTHYROIDISM ON BONE AND MINERAL METABOLISM IN MAN
ADAMS, P. H., Jowsey, J., Kelly, P. J., Riggs, B. L., KINNEY, V. R., & Jones, J. D. (1967) · QJM · doi:10.1093/oxfordjournals.qjmed.a067096 · Cited by 98
THE EFFECTS OF THYROTOXICOSIS UPON THE METABOLISM OF CALCIUM, PHOSPHORUS, AND NITROGEN1
Cook, P. B., Nassim, J. R., & COLLINS, J. (1959) · QJM · doi:10.1093/oxfordjournals.qjmed.a066855 · Cited by 94
The Role of Bone Biopsy in the Diagnosis of Metabolic Bone Disease
Melsen, F., & Mosekilde, L. (1981) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)31372-9 · Cited by 94
Self-citation
Research works printed but not linked: 1
- Parfitt, 1980, Kinetics of matrix and mineral apposition in osteoporosis and renal osteodystrophy. Relationship to rate of turnover and cell morphology, Metab. Bone Dis. Rel. Res., 2S, 213
Cited by
Sorted by citations
Bisphosphonates: A review of their pharmacokinetic properties
Lin, J. H. (1996) · Bone · doi:10.1016/8756-3282(95)00445-9 · Cited by 942
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Effects of thyroid hormones on bone and mineral metabolism
Mosekilde, L., Eriksen, E. F., & Charles, P. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30338-4 · Cited by 423
Self-citationBrixen, K., NIELSEN, H. K., Mosekilde, L., & Flyvbjerg, A. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050610 · Cited by 163
Self-citationMurphy, E., & Williams, G. R. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02053.x · Cited by 160
Levothyroxine dose and risk of fractures in older adults: nested case-control study
Turner, M. R., Camacho, X., Fischer, H. D., Austin, P. C., Anderson, G. M., Rochon, P. A., & Lipscombe, L. L. (2011) · BMJ · doi:10.1136/bmj.d2238 · Cited by 152
Markers of bone turnover in hyperthyroidism and the effects of treatment
Garnero, P., Vassy, V., Bertholin, A., Riou, J. P., & Delmas, P. D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.4.8157727 · Cited by 150
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Calcified Tissue International · doi:10.1007/s00223-005-0068-x · Cited by 146
Self-citationTrabecular bone remodeling and balance in primary hyperparathyroidism
Eriksen, E. F., Mosekilde, L., & Melsen, F. (1986) · Bone · doi:10.1016/8756-3282(86)90020-7 · Cited by 143
Self-citationHeemstra, K. A., Hamdy, N. A. T., Romijn, J. A., & Smit, J. W. A. (2006) · Thyroid · doi:10.1089/thy.2006.16.583 · Cited by 134
Hypercalcemic Disorders in Children
Stokes, V. J., Nielsen, M. F., Hannan, F. M., & Thakker, R. V. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3296 · Cited by 148
Eriksen, E. F., Mosekilde, L., & Melsen, F. (1986) · Bone · doi:10.1016/8756-3282(86)90681-2 · Cited by 121
Self-citationHigh, W. B. (1987) · Bone · doi:10.1016/8756-3282(87)90068-8 · Cited by 114
Charles, P., Mosekilde, L., Risteli, L., Risteli, J., & Eriksen, E. F. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80147-x · Cited by 113
Self-citationRosen, C. J., & Adler, R. A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464660 · Cited by 110
Mastaglia, S. R., Seijo, M., Muzio, D., Somoza, J., Núñez, M., & Oliveri, B. (2010) · The journal of nutrition health & aging · doi:10.1007/s12603-010-0287-3 · Cited by 100
Taelman, P., Kaufman, J.-M., Janssens, X., Vandecauter, H., & Vermeulen, A. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00471.x · Cited by 100
Oral Tori Are Associated With Local Mechanical and Systemic Factors: A Case-Control Study
Morrison, M. D., & Tamimi, F. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2012.08.005 · Cited by 98
Harper, K. D., & Weber, T. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70008-6 · Cited by 85
Thyroxine suppressive therapy decreases bone mineral density in post‐menopausal women
Kung, A. W., Lorentz, T., & Tam, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02405.x · Cited by 86
Melsen, F., & Steiniche, T. (1993) · Osteoporosis International · doi:10.1007/bf01621876 · Cited by 85
Self-citationLehmke, J., Bogner, U., Felsenberg, D., Peters, H., & Schleusener, H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02254.x · Cited by 84
Metabolic and Clinical Consequences of Hyperthyroidism on Bone Density
Gorka, J., Taylor‐Gjevre, R. M., & Arnason, T. (2013) · International Journal of Endocrinology · doi:10.1155/2013/638727 · Cited by 83
Pharmacokinetic Considerations in Determining the Terminal Elimination Half-Lives of Bisphosphonates
Lasseter, K. C., Porras, A. G., Denker, A. E., Santhanagopal, A., & Daifotis, A. G. (2005) · Clinical Drug Investigation · doi:10.2165/00044011-200525020-00003 · Cited by 68
Effects of Thyroid Hormone Administration and Estrogen Deficiency on Bone Mass of Female Rats
Gouveia, C. H. D. A., Jorgetti, V., & Bianco, A. C. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.12.2098 · Cited by 68
Tauchmanovà, L., Nuzzo, V., Del Puente, A., Fonderico, F., Esposito-Del Puente, A., Padulla, S., Rossi, A., Bifulco, G., Lupoli, G., & Lombardi, G. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.02.017 · Cited by 66
Jiang, Y., Zhang, Y., Chen, W., Liu, C., Li, X., Sun, D., Liu, Z., Xu, Y., Mao, X., Guo, Q., et al. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0334-7 · Cited by 65
Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment
Stepan, J. J., & Limanova, Z. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90787-e · Cited by 65
NORMAL AND ABNORMAL BONE REMODELING IN MAN
Marcus, R. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.001021 · Cited by 65
Wexler, J. A., & Sharretts, J. M. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.04.005 · Cited by 61
Heemstra, K., van der Deure, W. M., Peeters, R., Hamdy, N., Stokkel, M., Corssmit, E., Romijn, J., Visser, T., & Smit, J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0038 · Cited by 64
Steiniche, T., Hasling, C., Charles, P., Eriksen, E. F., Melsen, F., & Mosekilde, L. (1991) · Bone · doi:10.1016/8756-3282(91)90038-k · Cited by 58
Self-citationHistomorphometric Analysis of Bone in Metabolic Bone Disease
Eriksen, E. F., Steiniche, T., Mosekilde, L., & Meisen, F. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30349-9 · Cited by 58
Self-citationVitamin D Receptor Initiation Codon Polymorphism in Japanese Patients with Graves' Disease
Ban, Y., Ban, Y., Taniyama, M., & Katagiri, T. (2000) · Thyroid · doi:10.1089/thy.2000.10.375 · Cited by 56
Study of calcium homeostasis in feline hyperthyroidism
Barber, P. J., & Elliott, J. (1996) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.1996.tb02333.x · Cited by 55
Longitudinal Changes of Bone Density and Bone Resorption in Hyperthyroid Girls During Treatment
Mora, S., Weber, G., Marenzi, K., Signorini, E., Rovelli, R., Proverbio, M. C., & Chiumello, G. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.11.1971 · Cited by 53
Johansson, C., & Mellström, D. (1996) · Maturitas · doi:10.1016/0378-5122(95)01024-6 · Cited by 53
Effect of replacement doses of thyroxine on bone mineral density
Hanna, F., Pettit, R. J., Ammari, Evans, W. D., Sandeman, D. D., & Lazarus, J. H. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3871200.x · Cited by 53
A histomorphometric study of bone changes in thyroid dysfunction in rats
Allain, T., THOMAS, M., McGregor, A. M., & Salisbury, J. R. (1995) · Bone · doi:10.1016/8756-3282(95)00074-n · Cited by 53
The Role of Biochemical Tests in the Screening and Monitoring of Osteoporosis
Price, C. P., & Thompson, P. W. (1995) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329503200302 · Cited by 48
Yoon, B.-H., Lee, Y., Oh, H. J., Kim, S. H., & Lee, Y.-K. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.1.51 · Cited by 46
Remodeling of Mineralized Tissues, Part I: The Frost Legacy
Roberts, W. E., Roberts, J. A., Epker, B. N., Burr, D. B., & Hartsfield, J. K. (2006) · Seminars in Orthodontics · doi:10.1053/j.sodo.2006.08.002 · Cited by 42
Hoffman, S. J., Vasko-Moser, J. A., Miller, W. H., Lark, M. W., Gowen, M., & Stroup, G. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.205 · Cited by 42
Miyazaki, T., Matsunaga, T., Miyazaki, S., Hokari, S., & Komoda, T. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20201 · Cited by 41
The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats
Yamamoto, M., Markatos, A., Seedor, J. G., Masarachia, P. J., Gentile, M., Rodan, G. A., & Balena, R. (1993) · Calcified Tissue International · doi:10.1007/bf01320914 · Cited by 41
Hinton, P. S., LeCheminant, J. D., SMITH, B. K., Rector, R. S., & Donnelly, J. E. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719788 · Cited by 40
Yanagisawa, T., Sato, K., Kato, Y., Shimizu, S., & Takano, K. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.29 · Cited by 39
Charles, P., Eriksen, E. F., Mosekilde, L., Melsen, F., & Jensen, F. T. (1987) · Metabolism · doi:10.1016/0026-0495(87)90237-x · Cited by 37
Self-citationOsteoporosis: Clinical Features, Prevention, and Treatment
Gambert, S. R., Schultz, B. M., & Hamdy, R. C. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30044-6 · Cited by 36
Drug-Induced Metabolic Bone Disease
Wolinsky-Friedland, M. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30046-x · Cited by 35
Hwangbo, Y., Kim, J. H., Kim, S. W., Park, Y. J., Park, D. J., Kim, S. Y., Shin, C. S., & Cho, N. H. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3270-3 · Cited by 34
Reconstruction of the formative site in trabecular bone by a new, quick, and easy method
Steiniche, T., Eriksen, E. F., Kudsk, H., Mosekilde, L., & Melsen, F. (1992) · Bone · doi:10.1016/8756-3282(92)90004-g · Cited by 34
Self-citationSteiniche, T. (1995) · Apmis · doi:10.1111/j.1600-0463.1995.tb05544.x · Cited by 34
Remodeling of Mineralized Tissues, Part II: Control and Pathophysiology
Roberts, W. E., Epker, B. N., Burr, D. B., Hartsfield, J. K., & Roberts, J. A. (2006) · Seminars in Orthodontics · doi:10.1053/j.sodo.2006.08.003 · Cited by 34
Fractures following thyroidectomy in women: a population-based cohort study
Melton, L. J., Ardila, E., Crowson, C. S., O’Fallon, W. M., & Khosla, S. (2000) · Bone · doi:10.1016/s8756-3282(00)00379-3 · Cited by 32
Vitamin D Receptor Initiation Codon Polymorphism in Japanese Patients with Graves' Disease
Ban, Y., Ban, Y., Taniyama, M., & Katagiri, T. (2000) · Thyroid · doi:10.1089/thy.2000.10.475 · Cited by 32
Lupoli, G., Nuzzo, V., Carlo, C. D., Affmito, P., Vollery, M., Vitale, G., Cascone, E., Arlotta, F., & Nappi, C. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609012821 · Cited by 32
Trabecular mapping: Leveraging geometric morphometrics for analyses of trabecular structure
Sylvester, A. D., & Terhune, C. E. (2017) · American Journal of Physical Anthropology · doi:10.1002/ajpa.23231 · Cited by 33
Fractures After Thyroidectomy in Men: A Population-Based Cohort Study
Nguyen, T. T., Heath, H., Bryant, S. C., O'Fallon, W. M., & Melton, L. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1092 · Cited by 31
Bone Remodeling and Bone Structure
Eriksen, E. F., Vesterby, A., Kassem, M. S., Melsen, F., & Mosekilde, L. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6_2 · Cited by 31
Self-citationExogenous triiodothyronine activates bone remodeling
Hasling, C., Eriksen, E. F., Charles, P., & Mosekilde, L. (1987) · Bone · doi:10.1016/8756-3282(87)90072-x · Cited by 31
Self-citationAppetecchia, M. (2005) · Hormone Research in Paediatrics · doi:10.1159/000089489 · Cited by 30
Mankin, H. J. (1994) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199405000-00019 · Cited by 30
Karimifar, M., Karimifar, M., Salari, A., Esmaili, F., Faragzadegan, Z., & Kachuei, A. (2014) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.141099 · Cited by 30
Oikawa, M., Kushida, K., Masaaki, T., Ohishi, T., Hoshino, H., Suzuki, M., Ogihara, H., ISHIGAKI, J., & Inoue, T. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00626.x · Cited by 29
Biochemical bone turnover markers in hormonal disorders in adults: a narrative review
Szulc, P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01269-7 · Cited by 30
Hadji, P., Hars, O., Sturm, G., Bauer, T., Emons, G., & Schulz, K. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420445 · Cited by 28
Teixeira, M. B. C. G., Martins, G. M., Miranda-Rodrigues, M., Araújo, I. F. D., Oliveira, R., Brum, P. C., & Gouveia, C. H. D. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146795 · Cited by 26
Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
Kim, E. H., Jeon, Y. K., Pak, K., Kim, I.-J., Kim, S.-J., Shin, S., Kim, B. H., Kim, S. S., Lee, B.-J., Lee, J.-G., et al. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.1.31 · Cited by 26
Zhou, Z., Lin, Y., Pan, C., Wang, N., Zhou, L., Shan, H., Gao, Y., & Yu, X. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00190-0 · Cited by 25
Nicolaisen, P., Obling, M. L., Winther, K. H., Hansen, S., Hermann, A. P., Hegedűs, L. D., Bonnema, S. J., & Brix, T. H. (2020) · Thyroid · doi:10.1089/thy.2020.0084 · Cited by 24
Bone Mineral Density After Surgical Treatment for Graves' Disease
Arata, N., Momotani, N., Maruyama, H., Saruta, T., TSUKATANI, K., Kubo, A., IKEMOTO, K., & Ito, K. (1997) · Thyroid · doi:10.1089/thy.1997.7.547 · Cited by 23
Ishida, H., Bellows, C. G., Aubin, J. E., & Heersche, J. N. M. (1995) · Bone · doi:10.1016/8756-3282(95)00102-j · Cited by 22
Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues
Venditti, P., Stefano, L. D., & Meo, S. D. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1217-9 · Cited by 21
European and North American experience with HRT for the prevention of osteoporosis
Eriksen, E. F. (1996) · Bone · doi:10.1016/s8756-3282(96)90162-3 · Cited by 21
Self-citationSkeletal morphofunctional considerations and the pituitary-thyroid axis
Iqbal, J. Z. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e9 · Cited by 20
Zeni, S. N., Acotto, C. G., Gregorio, S. D., & Mautalén, C. (2000) · Calcified Tissue International · doi:10.1007/s00223001106 · Cited by 20
Efeito da associação hipertireoidismo-castração no osso de ratas adultas
Serákides, R., Nunes, V. A., Ocarino, N. M., & Nascimento, E. F. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000600015 · Cited by 20
Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment
Mosekilde, L., Eriksen, E. F., & Charles, P. (1991) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(91)90015-5 · Cited by 20
Self-citationАлександровна, С. Е., Silin, A. V., & Ramirez-Yañez, G. O. (2014) · Journal of Clinical Pediatric Dentistry · doi:10.17796/jcpd.38.4.2vh1603n62878673 · Cited by 18
Ock, S. Y., Chung, Y., & Choi, Y. J. (2016) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2016.05.004 · Cited by 19
Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?
Zimmermann‐Belsing, T., Tofteng, C. L., Langdahl, B. L., Charles, P., & Feldt‐Rasmussen, U. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-72 · Cited by 18
Langdahl, B. L., Loft, A. G., Møller, N., Weeke, J., Eriksen, E. F., Mosekilde, L., & Charles, P. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.78 · Cited by 18
Self-citationSkeletal responsiveness to thyroid hormone is not altered at menopause
Langdahl, B. L., Loft, A. G., Møller, N., Weeke, J., Eriksen, E. F., Mosekilde, L., & Charles, P. (1996) · Bone · doi:10.1016/s8756-3282(96)00247-5 · Cited by 17
Self-citationThyroid Hormone Signaling in the Development of the Endochondral Skeleton
Lindsey, R. C., Aghajanian, P., & Mohan, S. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.06.003 · Cited by 16
Superscan Pattern on Bone Scintigraphy: A Comprehensive Review
Askari, E., Shakeri, S., Roustaei, H., Fotouhi, M., Sadeghi, R., Harsini, S., & Vali, R. (2024) · Diagnostics · doi:10.3390/diagnostics14192229 · Cited by 15
Siderova, M. V., Hristozov, K., & Tsukeva, A. Z. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000027 · Cited by 15
Obermayer-Pietsch, B. M., Dobnig, H., Warnkross, H., Dimai, H. P., Weber, K., Berghold, A., & Leb, G. (2000) · Maturitas · doi:10.1016/s0378-5122(00)00114-6 · Cited by 15
Yamakita, N., Murai, T., Kokubo, Y., Hayashi, M., Akai, A., & Yasuda, K. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01420.x · Cited by 15
Association of the Vitamin D Receptor Genotype BB with Low Bone Density in Hyperthyroidism
Obermayer-Pietsch, B. M., Frühauf, G. E., Chararas, K., Mikhail-Reinisch, S., Renner, W., Berghold, A., Kenner, L., & Lackner, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1950 · Cited by 15
Liu, C., Yang, Y., Sun, D., Wang, C., Wang, H., Jia, S., Liu, L., & Lin, N. (2015) · Rejuvenation Research · doi:10.1089/rej.2015.1688 · Cited by 14
Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss
Christy, A. L., D'Souza, V., Babu, R. P., Takodara, S., Manjrekar, P., Hegde, A., & Rukmini, M. S. (2014) · Biomarker Insights · doi:10.4137/bmi.s13965 · Cited by 14
Mosekilde, L., Hasling, C., Charles, P., & Jensen, F. T. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01153.x · Cited by 14
Self-citationA novel mathematical model of bone remodelling cycles for trabecular bone at the cellular level
Ji, B., Genever, P. G., Patton, R. J., Putra, D., & Fagan, M. J. (2012) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-011-0366-3 · Cited by 14
Panebianco, P., Rosso, D., Destro, G., Scarpinato, R. A., Tropea, S., Rizzo, A., Russo, M., Motta, M., Stefano, F. D., Mazzarella, R., et al. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(97)00013-7 · Cited by 13
A 64-Year-Old Woman With Primary Hyperparathyroidism
Strewler, G. J. (2005) · JAMA · doi:10.1001/jama.293.14.1772 · Cited by 13
Sefati, N., Norouzian, M., Abbaszadeh, H., Abdollahifar, M., Amini, A., Bagheri, M., Aryan, A., & Fathabady, F. F. (2018) · PubMed Central · doi:10.22034/ibj.22.2.90 · Cited by 12
Effects of electromagnetic fields on bone loss in hyperthyroidism rat model
Liu, C., Zhang, Y., Fu, T., Liu, Y., Wei, S., Yong, Y., Zhao, D., Zhao, W., Song, M., Tang, X., et al. (2016) · Bioelectromagnetics · doi:10.1002/bem.22022 · Cited by 12
Amashukeli, M., Korinteli, M., Zerekidze, T., Jikurauli, N., Shanava, S., Tsagareli, M., & Giorgadze, E. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31828fcafb · Cited by 11
Yamaura, M., Nakamura, T., Kanou, A., Miura, T., Ohara, H., & Suzuki, K. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80129-8 · Cited by 11
Metadata
- Authors
- Eriksen, E. F., Mosekilde, L., & Melsen, F.
- Corresponding author
- Eriksen, E.F.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 1985-01
- Volume
- 6
- Issue
- 6
- Pages
- 421-428
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2051022943
- Cited by
- 172
- References
- 17
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 4 · 2013: 2 · 2012: 3
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bone (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- hyperthyroidism, trabecular bone remodeling, bone balance, tetracycline double labeling, iliac crest bone biopsy, bone resorption rate, bone formation rate, formation thickness, mineralization lag time, osteoclasts, bone turnover markers
- MeSH terms
- Adult, Aged, Bone Matrix, Bone Resorption, Female, Humans, Hyperthyroidism, Male, Middle Aged, Minerals, Osteogenesis, Regression Analysis, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review